Infectious Diseases (all articles)
M-A | Efficacy and safety of treatments for different stages of syphilis.
18 Nov, 2022 | 13:20h | UTC
SR | Mosquito aquatic habitat modification and manipulation interventions to control malaria.
17 Nov, 2022 | 12:06h | UTC
M-A | A short course of antibiotics is noninferior to long-course therapy in children with nonsevere pneumonia.
16 Nov, 2022 | 13:43h | UTCShort-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)
Commentary: Review: Shorter antibiotic course sufficient for kids with pneumonia – CIDRAP
Related:
ACP Guidance: Appropriate Use of Short-Course Antibiotics in Common Infections
RCT: 7 days of antibiotic therapy as good as 14 days for afebrile men with urinary tract infection.
Meta-Analysis: Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia
RCT | Evaluation of two short, standardized regimens for the treatment of rifampicin-resistant tuberculosis.
15 Nov, 2022 | 12:57h | UTCCommentary:
Shorter treatment effective for drug-resistant tuberculosis – University College London
Shorter Treatment Regimen for Drug-Resistant TB is More Effective – Health Policy Watch
RCT | Helicobacter pylori eradication may prevent peptic ulcer bleeding in older patients prescribed aspirin in primary care.
11 Nov, 2022 | 14:00h | UTCNews Release: Cutting the risk of stomach bleeding, occasionally caused by regular aspirin use – University of Nottingham
Commentary on Twitter
New @TheLancet – the HEAT trial of H pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (1/4)https://t.co/9SlP3y6DGf #gitwitter #medtwitter
— Rob Brierley (@Rob__Brierley) November 4, 2022
SR | Biomarkers as point‐of‐care tests to guide use of antibiotics in people with acute respiratory infections in primary care.
11 Nov, 2022 | 13:47h | UTC
RCT | No benefit from a model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients.
11 Nov, 2022 | 13:46h | UTC
Commentary on Twitter
Individualising beta-lactam ABTs/ciprofoxacin therapy in #ICU using model-informed precision dosing vs standard dosing, multicentre ?? RCT
No evidence for clinical effect of MIPD on LOS or other secondary outcomes in critically ill pts#FOAMcc @yourICM
?️https://t.co/6HzLBBnFdU pic.twitter.com/uErsHNAV5p— Intensive Care Medicine (@yourICM) November 9, 2022
Phase 2b RCT | Efficacy and safety of Bepirovirsen in chronic Hepatitis B infection.
11 Nov, 2022 | 13:44h | UTCEfficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In a phase 2 trial, bepirovirsen, an antisense oligonucleotide that targets all hep B virus (HBV) messenger RNAs, resulted in sustained loss of hep B surface antigen and HBV DNA in 9 to 10% of participants with chronic HBV infection. #TLM22 #LiverTwitter https://t.co/krJcMEDhIX pic.twitter.com/SistuAocZO
— NEJM (@NEJM) November 8, 2022
Editorial | The urgent need to recognize and properly address prenatal-onset group B Streptococcus disease.
10 Nov, 2022 | 13:59h | UTC
RCT | Efficacy of 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide for treatment of fluoroquinolone-sensitive MDR-TB.
9 Nov, 2022 | 12:11h | UTC9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea – The Lancet (link to abstract – $ for full-text)
RCT | Moxidectin and albendazole vs. ivermectin and albendazole in adolescents infected with Trichuris trichiura.
9 Nov, 2022 | 12:10h | UTCInvited Commentary: Alternative treatment strategies for trichuriasis – The Lancet Infectious Diseases
Guideline | Antibiotic prophylaxis for tube thoracostomy placement in trauma.
8 Nov, 2022 | 12:19h | UTC
Guidelines for empirical antibacterial therapy of sepsis in adults.
7 Nov, 2022 | 12:40h | UTC
Review | Early appropriate diagnostics and treatment of MDR Gram-negative infections.
7 Nov, 2022 | 12:19h | UTCRelated:
Commentary on Twitter
This is a ⚡fantastic article⚡
by super ?s Dr. Bassetti & @davidvanduin @jac_amr
We really need more adoption to RDTs coupled with stewardship programs
Early appropriate diagnostics and treatment of MDR Gram-negative infections #IDTwitter #MedEd https://t.co/h6eOvK2iH8 pic.twitter.com/WBjogJ6IYu— Antibiotic Steward Bassam Ghanem?? (@ABsteward) September 14, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
Review | The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections.
7 Nov, 2022 | 12:17h | UTCRelated:
Review | How and when to manage respiratory infections out of hospital.
7 Nov, 2022 | 12:15h | UTCHow and when to manage respiratory infections out of hospital – European Respiratory Review
M-A | Prevalence, risk factors and treatments for post-COVID-19 breathlessness.
7 Nov, 2022 | 12:14h | UTC
Review | Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD.
7 Nov, 2022 | 12:11h | UTC
Review | Non-Aspergillus mold lung infections.
7 Nov, 2022 | 11:51h | UTCNon-Aspergillus mould lung infections – European Respiratory Review
Review | Respiratory viruses: their importance and lessons learned from COVID-19.
7 Nov, 2022 | 11:54h | UTC
A multinational Delphi consensus to end the COVID-19 public health threat.
4 Nov, 2022 | 14:01h | UTCA multinational Delphi consensus to end the COVID-19 public health threat – Nature
Perspective | Monkeypox — A sobering sentinel for pandemic preparedness and sexual health system capacity.
4 Nov, 2022 | 13:53h | UTCRelated:
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Commentary on Twitter
The monkeypox pandemic has highlighted lessons learned — and sometimes ignored — from Covid-19 and has illustrated the inadequacy of sexual health infrastructure and pandemic preparedness in the United States. https://t.co/jXuYoH9Wn2 pic.twitter.com/KcTqBuyEXi
— NEJM (@NEJM) November 2, 2022
Cohort Study | Covid-19 vaccine effectiveness among children and adolescents in Qatar.
4 Nov, 2022 | 13:51h | UTC
Commentary on Twitter
The 10-µg dose of BNT162b2 led to modest, rapidly waning protection against Covid-19 in children 5 to 11 years old. The 30-µg dose in adolescents gave greater, more durable protection; more so in 12-to-14-year-olds than in 15-to-17-year-olds. https://t.co/ddcqiR8jvO pic.twitter.com/M8oSFYoFlw
— NEJM (@NEJM) November 2, 2022
RCT | Clinical and cost-effectiveness of single stage compared vs. two-stage revision for hip prosthetic joint infection.
4 Nov, 2022 | 13:49h | UTC
RCT | Oral antimicrobial prophylaxis reduced surgical site infection after elective colorectal surgery.
4 Nov, 2022 | 13:48h | UTC